Premium
Feasibility of tocilizumab in ICU patients with COVID‐19
Author(s) -
Issa Nahéma,
Dumery Margot,
Guisset Olivier,
Mourissoux Gaelle,
Bonnet Fabrice,
Camou Fabrice
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26110
Subject(s) - tocilizumab , medicine , hydroxychloroquine , cytokine release syndrome , intensive care unit , ards , covid-19 , pneumonia , fraction of inspired oxygen , respiratory distress , gastroenterology , anesthesia , mechanical ventilation , rheumatoid arthritis , lung , infectious disease (medical specialty) , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom